11th May 2006 16:16
GlaxoSmithKline PLC11 May 2006 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, PersonsDischarging Managerial Responsibility or Connected Persons in the OrdinaryShares of GlaxoSmithKline plc. 9 May 2006 Abacus (GSK) Trustees Limited, as trustee of the GlaxoSmithKline Employee Trust, ("the GSK Trust"), transferred 158,125 Ordinary Shares in the Company to participants in the SmithKline Beecham Employee Share Option Plan 1991. 10 May 2006 The GSK Trust transferred 584,286 Ordinary Shares in the Company to participants in the SmithKline Beecham Employee Share Option Plan 1991. 10 May 2006 The GSK Trust sold 775 Ordinary Shares in the Company on behalf of participants in the SmithKline Beecham Mid-Term Incentive Plan at a price of £15.57 per share. 10 May 2006 The GSK Trust transferred 1,137 Ordinary Shares in the Company to participants in the SmithKline Beecham Mid-Term Incentive Plan. The Company was advised of these transactions on 11 May 2006. The GSK Trust is a discretionary trust of which all employees or formeremployees of GlaxoSmithKline plc and its subsidiaries are potentialbeneficiaries. Three of the Company's directors, Dr J-P Garnier, Dr T Yamada andMr J S Heslop are therefore interested in the shares held in the GSK Trust fromtime to time in the same way as other employees or former employees ofGlaxoSmithKline plc and its subsidiaries. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(b). S M BicknellCompany Secretary 11 May 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline